Concepedia
Statistics
Publications
39
Citations
3.4K
H-Index
26
Active since
1986
Affiliations
Amgen (United States)(Current)
Johns Hopkins University
Bayer (United States)
University of Toronto
Johns Hopkins Medicine
John T. Sullivan is an author at Amgen (United States) specializing in medicine, pharmacology, and pharmacotherapy.
Top concepts
MedicinePharmacologyPharmacotherapyPharmacokineticsHealthAddictionAddiction MedicinePsychiatryToxicologySubstance Abuse
Publications per year
1986–2019
THE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVE
Thorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf et al. · Drug Metabolism and Disposition · 2003 · 781 citations
The Conduct of In Vitro and In Vivo Drug‐Drug Interaction Studies: A PhRMA Perspective
Thorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf et al. · The Journal of Clinical Pharmacology · 2003 · 309 citations
Drug Interactions, Preclinical Drug Evaluation, Biochemistry +14
Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand
Bo Wang, JL Nichol, John T. Sullivan · Clinical Pharmacology & Therapeutics · 2004 · 290 citations
The serotonin uptake inhibitor citalopram attenuates ethanol intake
Claudio A. Naranjo, Edward M. Sellers, John T. Sullivan et al. · Clinical Pharmacology & Therapeutics · 1987 · 240 citations
Effects of a novel glucagon receptor antagonist (Bay 27-9955) on glucagon-stimulated glucose production in humans
Kitt Falk Petersen, John T. Sullivan · Diabetologia · 2001 · 207 citations · Full text
Metabolic Syndrome, Molecular Pharmacology, Bay 27-9955 +11
1–5 of 39